Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iain A M MacPhee

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Therapeutic Drug Monitoring|May 1, 2010
Use of pharmacogenetics to optimize immunosuppressive therapyIain A M Macphee
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 1, 2011
Pharmacogenetic biomarkers: cytochrome P450 3A5Iain A M MacPhee
Current Opinion in Molecular Therapeutics|June 4, 2010
Current progress in pharmacogenetics and individualized immunosuppressive drug dosing in organ transplantationNicholas Ware, Iain A M MacPhee
Transplantation|January 24, 2008
A pharmacogenetic strategy for immunosuppression based on the CYP3A5 genotypeIain A M MacPhee, David W Holt
Expert Opinion on Pharmacotherapy|December 1, 2005
Does pharmacogenetics have the potential to allow the individualisation of immunosuppressive drug dosing in organ transplantation?Iain A M MacPhee, Salim Fredericks, David W Holt
Therapeutic Drug Monitoring|May 14, 2013
CYP3A5 genotype had no impact on intrapatient variability of tacrolimus clearance in renal transplant recipientsN Spierings, D W Holt, Iain A M MacPhee
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|October 25, 2003
The pharmacogenetics of immunosuppression for organ transplantation: a route to individualization of drug administrationSalim Fredericks, David W Holt, Iain A M MacPhee
Expert Opinion on Pharmacotherapy|August 24, 2007
Pharmacogenetics as a tool for optimising drug therapy in solid-organ transplantationFu Liang Ng, David W Holt, Iain A M MacPhee
Critical Care Research and Practice|March 12, 2013
Estimated glomerular filtration rate correlates poorly with four-hour creatinine clearance in critically ill patients with acute kidney injuryChristopher J Kirwan, Barbara J Philips, Iain A M Macphee
Immunology|February 16, 2006
Blockade of OX40-ligand after initial triggering of the T helper 2 response inhibits mercuric chloride-induced autoimmunityIain A M MacPhee, Hideo Yagita, David B G Oliveira
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Therapeutic Drug Monitoring|May 1, 2010
Use of pharmacogenetics to optimize immunosuppressive therapyIain A M Macphee
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 1, 2011
Pharmacogenetic biomarkers: cytochrome P450 3A5Iain A M MacPhee
Current Opinion in Molecular Therapeutics|June 4, 2010
Current progress in pharmacogenetics and individualized immunosuppressive drug dosing in organ transplantationNicholas Ware, Iain A M MacPhee
Transplantation|January 24, 2008
A pharmacogenetic strategy for immunosuppression based on the CYP3A5 genotypeIain A M MacPhee, David W Holt
Expert Opinion on Pharmacotherapy|December 1, 2005
Does pharmacogenetics have the potential to allow the individualisation of immunosuppressive drug dosing in organ transplantation?Iain A M MacPhee, Salim Fredericks, David W Holt
Therapeutic Drug Monitoring|May 14, 2013
CYP3A5 genotype had no impact on intrapatient variability of tacrolimus clearance in renal transplant recipientsN Spierings, D W Holt, Iain A M MacPhee
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|October 25, 2003
The pharmacogenetics of immunosuppression for organ transplantation: a route to individualization of drug administrationSalim Fredericks, David W Holt, Iain A M MacPhee
Expert Opinion on Pharmacotherapy|August 24, 2007
Pharmacogenetics as a tool for optimising drug therapy in solid-organ transplantationFu Liang Ng, David W Holt, Iain A M MacPhee
Critical Care Research and Practice|March 12, 2013
Estimated glomerular filtration rate correlates poorly with four-hour creatinine clearance in critically ill patients with acute kidney injuryChristopher J Kirwan, Barbara J Philips, Iain A M Macphee
Immunology|February 16, 2006
Blockade of OX40-ligand after initial triggering of the T helper 2 response inhibits mercuric chloride-induced autoimmunityIain A M MacPhee, Hideo Yagita, David B G Oliveira
Pageof 3